Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 1
1985 1
1986 1
1987 2
1988 2
1989 1
1990 1
1991 1
1992 1
1995 3
1996 1
1997 1
1998 2
2000 1
2001 2
2002 2
2003 4
2004 5
2005 2
2006 7
2007 4
2008 2
2009 5
2010 4
2011 1
2012 10
2013 7
2014 7
2015 12
2016 6
2017 7
2018 4
2019 3
2020 6
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27807213

104 results
Results by year
Filters applied: . Clear all
Page 1
Tacrolimus Monotherapy after Intravenous Methylprednisolone in Adults with Minimal Change Nephrotic Syndrome.
Li X, Liu Z, Wang L, Wang R, Ding G, Shi W, Fu P, He Y, Cheng G, Wu S, Chen B, Du J, Ye Z, Tao Y, Huo B, Li H, Chen J. Li X, et al. J Am Soc Nephrol. 2017 Apr;28(4):1286-1295. doi: 10.1681/ASN.2016030342. Epub 2016 Nov 2. J Am Soc Nephrol. 2017. PMID: 27807213 Free PMC article. Clinical Trial.
Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Li H, Shi X, Shen H, Li X, Wang H, Li H, Xu G, Chen J. Li H, et al. Clin Ther. 2012 May;34(5):1112-20. doi: 10.1016/j.clinthera.2012.03.008. Epub 2012 Apr 12. Clin Ther. 2012. PMID: 22503105 Clinical Trial.
Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J. Li X, et al. Am J Kidney Dis. 2009 Jul;54(1):51-8. doi: 10.1053/j.ajkd.2009.02.018. Epub 2009 May 5. Am J Kidney Dis. 2009. PMID: 19406543
Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults.
Fukudome K, Fujimoto S, Sato Y, Kitamura K. Fukudome K, et al. Nephrology (Carlton). 2012 Mar;17(3):263-8. doi: 10.1111/j.1440-1797.2011.01544.x. Nephrology (Carlton). 2012. PMID: 22117558
Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W. Li X, et al. Nephrol Dial Transplant. 2008 Jun;23(6):1919-25. doi: 10.1093/ndt/gfm637. Epub 2007 Oct 1. Nephrol Dial Transplant. 2008. PMID: 17911091
Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M. Medjeral-Thomas NR, et al. Clin J Am Soc Nephrol. 2020 Feb 7;15(2):209-218. doi: 10.2215/CJN.06180519. Epub 2020 Jan 17. Clin J Am Soc Nephrol. 2020. PMID: 31953303
Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study.
Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Tomida K, Hayashi T, Izumi M, Fukunaga M, Yamauchi A, Tsubakihara Y, Isaka Y. Shinzawa M, et al. Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1040-8. doi: 10.2215/CJN.12331213. Epub 2014 Apr 10. Clin J Am Soc Nephrol. 2014. PMID: 24721890 Free PMC article.
Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
Xu D, Gao X, Bian R, Mei C, Xu C. Xu D, et al. Nephrology (Carlton). 2017 Mar;22(3):251-256. doi: 10.1111/nep.12991. Nephrology (Carlton). 2017. PMID: 28035723
An open-label randomized controlled trial of low-dose corticosteroid plus enteric-coated mycophenolate sodium versus standard corticosteroid treatment for minimal change nephrotic syndrome in adults (MSN Study).
Rémy P, Audard V, Natella PA, Pelle G, Dussol B, Leray-Moragues H, Vigneau C, Bouachi K, Dantal J, Vrigneaud L, Karras A, Pourcine F, Gatault P, Grimbert P, Ait Sahlia N, Moktefi A, Daugas E, Rigothier C, Bastuji-Garin S, Sahali D; MSN Trial Investigators. Rémy P, et al. Kidney Int. 2018 Dec;94(6):1217-1226. doi: 10.1016/j.kint.2018.07.021. Epub 2018 Oct 29. Kidney Int. 2018. PMID: 30385039 Clinical Trial.
Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome.
Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M. Westhoff TH, et al. Clin Nephrol. 2006 Jun;65(6):393-400. doi: 10.5414/cnp65393. Clin Nephrol. 2006. PMID: 16792133 Clinical Trial.
104 results
Jump to page
Feedback